These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


255 related items for PubMed ID: 18947469

  • 1. [A case of arterial chemoembolization for hepatocellular carcinoma with 11 years of survival].
    Iozzino M, Spaziani E, Saltarelli A, Notarianni E, Di Filippo A, Picchio M, Ceci F, De Angelis F, Cipriani B, Nardecchia G, Nicodemi S, Stagnitti F, Cianni R.
    G Chir; 2008 Oct; 29(10):432-6. PubMed ID: 18947469
    [Abstract] [Full Text] [Related]

  • 2. Long-term survival after transarterial chemoembolization for hepatocellular carcinoma.
    Iozzino M, Spaziani E, Picchio M, Saltarelli A, Di Filippo A, De Angelis F, Narilli F, Stagnitti F, Cianni R.
    Clin Ter; 2011 Oct; 162(2):129-32. PubMed ID: 21533319
    [Abstract] [Full Text] [Related]

  • 3. Histopathologic outcome of neoadjuvant image-guided therapy of hepatocellular carcinoma.
    Marin HL, Furth EE, Olthoff K, Shaked A, Soulen MC.
    J Gastrointestin Liver Dis; 2009 Jun; 18(2):169-76. PubMed ID: 19565046
    [Abstract] [Full Text] [Related]

  • 4. [Effectiveness of radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
    Gao HJ, Liang HH, Chen MS, Peng ZW, Zhang YJ, Li P, Pang XH, Zhang YQ, Li JQ.
    Zhonghua Yi Xue Za Zhi; 2008 Sep 23; 88(36):2529-32. PubMed ID: 19080642
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Treatment before liver transplantation for HCC.
    Belghiti J, Carr BI, Greig PD, Lencioni R, Poon RT.
    Ann Surg Oncol; 2008 Apr 23; 15(4):993-1000. PubMed ID: 18236111
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas larger than 5 cm.
    Takaki H, Yamakado K, Uraki J, Nakatsuka A, Fuke H, Yamamoto N, Shiraki K, Yamada T, Takeda K.
    J Vasc Interv Radiol; 2009 Feb 23; 20(2):217-24. PubMed ID: 19097810
    [Abstract] [Full Text] [Related]

  • 9. [Current treatment of hepatocellular carcinoma. Analysis of a series of 123 cases over a 5-year period].
    Popescu I, Ionescu M, Ciurea S, Braşoveanu V, Sârbu-Boeţi P, Hrehoreţ D, Tomulescu V, Alexandrescu S, Dorobanţu B, Grigorie R, Jemna C, Gheorghe L, Anghel R, Croitoru A, Herlea V, Boroş M.
    Chirurgia (Bucur); 2005 Feb 23; 100(4):321-31. PubMed ID: 16238194
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [A long-term survival of the patient with hepatocellular carcinoma and advanced portal vein and bile duct tumor thrombosis successfully treated with multimodal treatments].
    Tashima R, Beppu T, Nakagawa M, Ishiko T, Sugiyama S, Suyama K, Masuda T, Hirota M, Kanemitsu K, Okabe K, Yamanaka T, Sasaki Y, Baba H.
    Gan To Kagaku Ryoho; 2005 Oct 23; 32(11):1805-8. PubMed ID: 16315947
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pilot study of combination therapy with transcatheter arterial infusion chemotherapy using iodized oil and percutaneous radiofrequency ablation during occlusion of hepatic blood flow for hepatocellular carcinoma.
    Shiraishi R, Yamasaki T, Saeki I, Okita K, Yamaguchi Y, Uchida K, Terai S, Sakaida I.
    Am J Clin Oncol; 2008 Aug 23; 31(4):311-6. PubMed ID: 18845987
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Local ablative therapies in HCC: percutaneous ethanol injection and radiofrequency ablation.
    Mahnken AH, Bruners P, Günther RW.
    Dig Dis; 2009 Aug 23; 27(2):148-56. PubMed ID: 19546553
    [Abstract] [Full Text] [Related]

  • 18. Transcatheter chemoembolization of unresectable hepatocellular carcinoma: current knowledge and future directions.
    Maleux G, van Malenstein H, Vandecaveye V, Heye S, Vaninbroukx J, Nevens F, Verslype C.
    Dig Dis; 2009 Aug 23; 27(2):157-63. PubMed ID: 19546554
    [Abstract] [Full Text] [Related]

  • 19. [Clinical effect of transcatheter arterial chemoembolization combined with high intensity focused ultrasound ablation in treatment of large hepatocellular carcinoma].
    Li CX, Wu PH, Fan WJ, Huang JH, Zhang FJ, Zhang L, Gu YK, Zhao M, Gao F, Jiao DC.
    Zhonghua Yi Xue Za Zhi; 2009 Mar 24; 89(11):754-7. PubMed ID: 19595104
    [Abstract] [Full Text] [Related]

  • 20. Hepatocellular carcinoma with internal mammary artery supply: feasibility and efficacy of transarterial chemoembolization and factors affecting patient prognosis.
    Kim HC, Chung JW, Choi SH, Yoon JH, Lee HS, Jae HJ, Lee W, Park JH.
    J Vasc Interv Radiol; 2007 May 24; 18(5):611-9; quiz 620. PubMed ID: 17494842
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.